Oriola Q2 2026 slides: mixed results as freight costs pressure margins

This reads more like a cash-conversion warning than an earnings story. In a low-margin distribution model, flat EBITDA with negative free cash flow is the bigger signal because working capital can swamp operating improvements before the market notices; if receivables stay elevated, the net-cash cushion can shrink fast over the next 1-2 quarters. The near-term beneficiaries are competitors with denser route economics and stronger specialty mix, while weaker exposure to fast-growing categories means Oriola is likely surrendering share where mix is best.

The second-order issue is that fuel and freight inflation disproportionately punish smaller distributors and advisory-heavy models, even when they manage to protect reported margins via pricing or mix. Management’s transport optimization helps, but it is an incremental offset, not a structural fix if energy remains sticky; the real question is whether routing improvements and ERP spend translate into lower run-rate cash costs by H2 rather than just deferred expense.

Contrarianly, the market may be underestimating the equity option embedded in Kronans Apotek: if that JV can move from loss-making to durable positive EBIT, the rerating could be meaningful over 6-18 months. But the thesis is falsified quickly if Q3 shows no improvement in working capital or if the cash drag from ERP and receivables persists, because then balance-sheet strength becomes the valuation anchor, not growth.